Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration

NCT00140803 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Age-Related Macular Degeneration

Interventions

DRUG: Visudyne
DRUG: Kenalog

Sponsor

Manhattan Eye, Ear & Throat Hospital

Collaborators

[object Object]
[object Object]